William Z. Potter - Concepedia

Author

William Z. Potter

Also Known As

Andrew J. Saykin, Anthony Gamst, Bennett Ramberg, Davie Holtzman, Emily A. Meyers, Eric Siemers, H Ryan, John Hsiao, John Morris, L Nicholson

257

Publications

21.7K

Citations

H-Index

135

Concepts

All Affiliations

National Institute of Mental Health National Institute of Mental Health Eli Lilly (United States)National Institutes of Health Yale University

About

William Z. Potter is an author at National Institute of Mental Health specializing in medicine, pharmacology, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	56	4.4K
2	Social Sciences	19	25	1.3K
3	Health Sciences	9	9	1.8K
4	Natural Sciences	2	2	262
5	Anesthesia	2	2	45

William Z. Potter

100

Publications

14.5K

Citations

H-Index

Page 1

	Year	Citations
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Leslie M. Shaw, Hugo Vanderstichele, Małgorzata Knapik-Czajka, Annals of Neurology	2009	2.1K
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE J.R. Mitchell, David J. Jollow, William Z. Potter, Journal of Pharmacology and Experimental Therapeutics	1973	1.7K
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. I. ROLE OF DRUG METABOLISM John R. Mitchell, David J. Jollow, William Z. Potter, Journal of Pharmacology and Experimental Therapeutics	1973	1.5K
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO David J. Jollow, John R. Mitchell, William Z. Potter, Journal of Pharmacology and Experimental Therapeutics	1973	1.2K
Acetaminophen-induced Hepatic Necrosis David J. Jollow, S S Thorgeirsson, William Z. Potter, Pharmacology Mercapturic AcidLipid PeroxidationToxicological MechanismOxidative StressInflammation	1974	1.1K
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease N. Bodick, Walter Offen, Allan I. Levey, Archives of Neurology	1997	678
Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [<sup>11</sup>C]DASB Positron Emission Tomography Study Jeffrey H. Meyer, Alan A. Wilson, Sandra Sagrati, American Journal of Psychiatry	2004	512
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. William Z. Potter, Dawn C. Davis, John R. Mitchell, PubMed PharmacotherapyToxicological MechanismOxidative StressMolecular PharmacologyToxicology	1973	501
A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia Andrew D. Krystal, Diego A. Pizzagalli, Moria J. Smoski, Nature Medicine Pain DisordersHealth SciencesPsychiatryPain MedicineAddiction	2020	214
A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder Lobna Ibrahim, Nancy Diazgranados, Libby Jolkovsky, Journal of Clinical Psychopharmacology Psychotropic MedicationPsychopharmacologyPharmacotherapyMental HealthSocial Sciences	2012	212

Page 1